Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia

Clinical trial NCT05281809 · RECRUITING

Trial details

NCT number: NCT05281809
Sponsor: John Lister
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

B-Cell Lymphoma B Acute Lymphoblastic Leukemia Diffuse Large B Cell Lymphoma Mantle Cell Lymphoma Follicular Lymphoma Marginal Zone Lymphoma Lymphoplasmacytic Lymphoma Chronic Lymphocytic Leukemia Transformed Lymphoma

Start date: 2022-04-19
Primary completion: 2037-08-05
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.